Navigation Links
How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
Date:1/13/2017

NEW YORK, January 13, 2017 /PRNewswire/ --

On Thursday, January 12, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Seven out of nine sectors ended Thursday's trading session in bearish territories. Taking into consideration yesterday's market sentiment, Stock-Callers.com assessed the following Research Services equities this morning: Myriad Genetics Inc. (NASDAQ: MYGN), Qiagen N.V. (NASDAQ: QGEN), INC Research Holdings Inc. (NASDAQ: INCR), and La Quinta Holdings Inc. (NYSE: LQ). Download the free research reports on these stocks today:

http://stock-callers.com/registration

Myriad Genetics

Salt Lake City, Utah headquartered Myriad Genetics Inc.'s stock finished Thursday's session 1.55% higher at $16.37 with a total volume of 954,341 shares traded. The Company's shares are trading below its 50-day and 200-day moving averages by 5.42% and 36.82%, respectively. Shares of Myriad Genetics, which focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide, are trading at a PE ratio of 12.41. The stock has a Relative Strength Index (RSI) of 40.79. See our free and comprehensive research report on MYGN at:

http://stock-callers.com/registration/?symbol=MYGN


Qiagen

Venlo, the Netherlands headquartered Qiagen N.V.'s stock edged 0.35% lower, to close the day at $28.33. The stock recorded a trading volume of 797,791 shares. Qiagen's shares have gained 9.64% in the previous three months and 25.86% in the past one year. The Company's shares are trading 2.64% and 13.51% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which provides sample to insight solutions that transform biological samples into valuable molecular insights worldwide, are trading at a PE ratio of 56.89. Additionally, the stock has an RSI of 54.86. QGEN free research report PDF is just a click away at:

http://stock-callers.com/registration/?symbol=QGEN

INC Research

On Thursday, shares in Raleigh, North Carolina headquartered INC Research Holdings Inc. ended the session 0.58% lower at $51.55 with a total volume of 336,094 shares traded. INC Research Holdings' shares have advanced 1.88% in the last one month and 15.53% in the previous three months. Furthermore, the stock has gained 22.13% in the past one year. Shares of the Company, which provides various clinical development services for the biopharmaceutical and medical device industries, are trading at a PE ratio of 27.48. The stock is trading 2.68% above its 50-day moving average and 13.46% above its 200-day moving average. Moreover, the Company's shares have an RSI of 49.28.

On December 20th, 2016, research firm First Analysis Sec initiated an 'Equal-Weight' rating on the Company's stock, with a target price of $59 per share. Sign up for your complimentary report on INCR at:

http://stock-callers.com/registration/?symbol=INCR


La Quinta

On Thursday, shares in Irving, Texas headquartered La Quinta Holdings Inc. recorded a trading volume of 701,012 shares. The stock ended the day 1.44% lower at $14.38. Shares of the Company, which owns, operates, and franchises select-service hotels under the La Quinta brand, are trading at a PE ratio of 202.54. La Quinta Holdings' stock has gained 4.96% in the last one month, 35.02% in the previous three months, and 27.26% in the past one year. The Company is trading above its 50-day and 200-day moving averages by 13.36% and 20.93%, respectively. Furthermore, La Quinta Holdings' shares have an RSI of 64.71.

On January 10th, 2017, research firm Stifel reiterated its 'Hold' rating on the Company's stock with an increase of the target price from $10.25 a share to $13 a share. Register for free on Stock-Callers.com and download the latest research report on LQ at:

http://stock-callers.com/registration/?symbol=LQ

--

Stock Callers:

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP


CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.



'/>"/>
SOURCE Chelmsford Park SA
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. How These Medical Instruments Stocks are Faring? -- Cooper, Insulet, Glaukos, and C. R. Bard
2. How These Healthcare Stocks are Faring? -- Wright Medical, Varian Medical Systems, MiMedx, and WaferGen Bio-systems
3. How These Biotechs Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma
4. Why Investors Love These Medical Appliances & Equipments Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical
5. These Four Companies Deserve Your Attention in June
6. Why Investors Love These Scientific & Technical Instruments Stocks? - Trimble Navigation, Garmin, Cepheid, and Keysight Technologies
7. How These Biotechs Stocks are Performing? - Clovis Oncology, Illumina, NewLink Genetics and Zafgen
8. How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
9. Are These Biotech Stocks Prescribed for Investors Portfolio? - Anacor Pharma, Athersys, Aralez Pharma and Infinity Pharma
10. Grand Cayman Will Use Oxitec Solution to Suppress Wild Aedes aegypti, the Dangerous Mosquito that Spreads Dengue, Zika and Chikungunya, in an Effort to Help Eliminate These Diseases
11. Foot and Ankle Devices Market by Product, Prostheses, Bracing & by Cause of Injury - Trends & Global Forecasts to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
Breaking Medicine News(10 mins):